Frequency of
KRAS
p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer
JCO Glob Oncol
.
2021 Apr:7:639-645.
doi: 10.1200/GO.20.00615.
Authors
Rodrigo Cavagna
1
,
Flávia Escremim de Paula
2
,
Débora Sant'Anna
1
,
Iara Santana
2
3
,
Vinicius D da Silva
3
,
Eduardo C A da Silva
3
,
Carlos E Bacchi
4
,
José E Miziara
5
,
Josiane M Dias
6
,
Pedro De Marchi
1
6
7
,
Leticia F Leal
1
8
,
Rui M Reis
1
2
9
10
Affiliations
1
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
2
Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
3
Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.
4
Bacchi Laboratory, Botucatu, Brazil.
5
Department of Thoracic Surgery, Barretos Cancer Hospital, Barretos, Brazil.
6
Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil.
7
Oncoclinicas, Rio de Janeiro, Brazil.
8
Barretos School of Health Sciences, Dr Paulo Prata-FACISB, Barretos, Brazil.
9
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
10
ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
PMID:
33956502
PMCID:
PMC8162527
DOI:
10.1200/GO.20.00615
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Brazil
Humans
Lung Neoplasms* / genetics
Mutation
Proto-Oncogene Proteins p21(ras)* / genetics
Substances
KRAS protein, human
Proto-Oncogene Proteins p21(ras)